Evaluation of knee function and safety after treatment of knee articular cartilage damage with iPS-cell-derived cartilage.

Evaluation of knee function and safety after treatment of articular cartilage damage in knee joints with allogeneic induced pluripotent stem (iPS) cell-derived cartilage.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1050220051

Enrollment

Registered

2022-06-16

Start date

2022-06-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Damage of articular cartilage of the Knee Articular cartilage damage, Articular cartilage disorder, Osteoarthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received and completed knee treatment with iPS-cell-derived cartilage.

Exclusion criteria

Exclusion criteria: Patients whom the doctors considered inappropriate for the study. 1) Patients with new-onset systematic diseases unrelated to the surgery that can not come to the hospital.. 2) Patients who have difficulty coming to the hospital due to relocation. 3) Patients with new-onset psychiatric disorders that may influence the conduct and evaluation of this study.

Design outcomes

Primary

Measure	Time frame
Evaluation of clinical outcomes of patients who received treatment with iPS-cell-derived cartilage for at least one year postoperatively.	—

Secondary

Measure	Time frame
Evaluation of safety of patients who received treatment with iPS-cell-derived cartilage for at least one year postoperatively.	—

Contacts

Public ContactShinichi Kuriyama

Kyoto University Hospital

seikei@kuhp.kyoto-u.ac.jp+81-75-751-3366

Outcome results